GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (FRA:AYJ) » Definitions » Issuance of Stock

Valneva SE (FRA:AYJ) Issuance of Stock : €0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Valneva SE Issuance of Stock?

Valneva SE's Issuance of Stock for the three months ended in Dec. 2024 was €0.0 Mil.

Valneva SE's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was €0.0 Mil.

Valneva SE Issuance of Stock Historical Data

The historical data trend for Valneva SE's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Issuance of Stock Chart

Valneva SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 166.82 189.84 - -

Valneva SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Valneva SE Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Valneva SE's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (FRA:AYJ) » Definitions » Issuance of Stock
Comparable Companies
XPAR:MEDCL XPAR:ABVX XPAR:IVA XPAR:DBV XPAR:ALCLS XPAR:GNFT XPAR:IPH XPAR:NANO XPAR:OSE XPAR:MAAT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
VALN:USA INRLF:USA 0OB3:UK VLA:France AYJ:Germany AYJ0:Germany AYJ0:Germany AYJ:Germany AYJ:Germany AYJ:Bulgaria VLA:Austria
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Website
https://www.valneva.com
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Valneva SE Headlines

No Headlines